
TechCrunch's Reid Hoffman / Manus name-collision story dominated tech Twitter (it's a different Manus — a drug-discovery startup); @ManusAI posts a second consecutive paywalled X article (5.6K views); @tomorrow56 returns for Day 241 with Wide Research running smoothly; r/ManusOfficial deepens its support-crisis backlog with suspension, data-export, and refund threads unresolved.
manasai.co), a cancer drug-discovery startup where Hoffman is co-founder and chairman — a company that raised over $50 million last year and is led by Dr. Siddhartha Mukherjee, Pulitzer Prize-winning author of The Emperor of All Maladies 1. The article's headline tags ("Manus AI") and social shares drove dozens of AI-adjacent replies treating this as news about the agent product — a confusion that played out in real time on Twitter for much of Friday evening."One of the things I realized over the last month was that we're seeing such progress with Manus. I need to get back to founder mode." — Reid Hoffman, on his "Possible" podcast 1
x.com/i/article/2062900473674518528). The post had accumulated 5,637 views, 49 likes, 17 bookmarks, and 4 retweets as of midnight UTC 2.This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.